In this video interview, Heather Horville, solutions consultant at Greenphire, emphasizes the growing need for clinical operations to embed patient-centric services—from consent through final visit—to improve retention and overall trial success.
In a recent video interview with Applied Clinical Trials, Heather Horville, solutions consultant, Greenphire, discussed the challenges of retention and trial timelines due to increasing financial and logistical burdens on patients. Horville highlighted strategies to address these issues, such as early planning, patient advocacy, and site selection based on local needs. For complex trials, engagement through diary entries and stipends, and human interaction via concierge services will be critical. Future improvements will emphasize a comprehensive patient journey, incorporating services like travel prepayment to enhance trial success.
ACT: Looking ahead, how might clinical operations as a function evolve to better support the patient experience and, by extension, trial success?
Horville: I think that it's going to be more and more important to consider the entire patient journey from start to finish, really focusing on their experience and designing engagement throughout the life of the trial, from the initial consent and what that experience is, all the way through to the final visit and that final data collection. I think that's really going to be key. A lot of in line of what we've already been speaking about, but I think it's also important for the folks, the sponsors, really conducting these trials, to plan for these services to be in play, to engage patients, incorporating what used to be known as nice to have services like reimbursement, stipends, and travel, as really a way to ensure that we retain our patients throughout the trial. We know that we should be speaking to advocacy groups, reimbursing patients, and prepaying for travel. We know this, but all of these things cost money, and the data shows that they are more and more crucial in successive trials, so streamlining these services, ensuring that we're considering the site's experience, like we mentioned before, and planning to have these services involved can really help shape trial success in the future. I think it's just going to be more and more important to do so.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.